Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

ABCELLERA BIOLOGICS INC.

(ABCL)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op ABCELLERA BIOLOGICS INC.
14/10ABCELLERA BIOLOGICS : to Report Third Quarter 2021 Financial Results on November 9, 2021
12/10Salipro Biotech AB Enters into A Collaboration and License Agreement with Abcellera for..
23/09Health Care Stocks Slightly Higher in Premarket Thursday
23/09EVEREST MEDICINES : Strikes R&D Tie-Up with Nasdaq-listed AbCellera Biologics for Therapeu..
23/09ABCELLERA BIOLOGICS : Lilly to Supply the EU and EEA with up to 220,000 Doses of Bamlanivi..
23/09ABCELLERA BIOLOGICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
23/09ABCELLERA BIOLOGICS : Everest Medicines Enter Multi-Year Collaboration, License Agreement
23/09ABCELLERA BIOLOGICS : and Everest Medicines Announce Multi-Target Collaboration to Advance..
23/09Abcellera Biologics Inc. and Everest Medicines Limited Announces Multi-Target Collabora..
21/09ABCELLERA BIOLOGICS : Lilly to Supply the EU and EEA with up to 220,000 Doses of Bamlanivi..
21/09ABCELLERA BIOLOGICS : Lilly to Supply the EU and EEA with up to 220,000 Doses of AbCellera..
21/09Abcellera Biologics Inc. Announces the European Commission and Eli Lilly and Company Ha..
17/09AFTER HOURS WATCH LIST SCORECARD : Abcl, fang, grts
17/09ABCELLERA BIOLOGICS : Health Care Stocks Down to End Week
17/09Health Care Stocks Mixed Premarket Friday
17/09ABCELLERA BIOLOGICS : Lilly Announce Expanded FDA Emergency Use Authorization for COVID-19..
16/09MT NEWSWIRES AFTER HOURS WATCH LIST : Abcl, fang, grts
16/09ABCELLERA BIOLOGICS : Jumps 20% After Hours as FDA Expands Emergency Use Authorization for..
16/09ABCELLERA BIOLOGICS : Lilly Announce Expanded FDA Emergency Use Authorization for COVID-19..
16/09ABCELLERA BIOLOGICS : Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Adm..
16/09Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etes..
15/09ABCELLERA BIOLOGICS : Acquisition expands AbCellera's existing capabilities to unlock diff..
15/09ABCELLERA BIOLOGICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
15/09ABCELLERA BIOLOGICS : Moderna Enter mRNA-Encoded Antibody Therapeutic Collaboration
15/09ABCELLERA BIOLOGICS : Announces Collaboration with Moderna to Discover Therapeutic Antibod..
13/09ABCELLERA BIOLOGICS : Buys TetraGenetics
13/09ABCELLERA BIOLOGICS : Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodie..
13/09AbCellera Biologics Inc. acquired TetraGenetics, Inc.
10/09ABCELLERA : to Present Virtually at the BofA Securities – Tech Solutions for Drug Di..
13/08ABCELLERA BIOLOGICS : Management's Discussion and Analysis of Financial Condition and Resu..
13/08SECTOR UPDATE : Health Cares Higher Late Afternoon But Biotechs Slipping
13/08SECTOR UPDATE : Health Care Stocks Advancing This Afternoon
12/08ABCELLERA BIOLOGICS : Reports Q2 2021 Business Results (Form 8-K)
12/08ABCELLERA BIOLOGICS INC. : Results of Operations and Financial Condition, Regulation FD Di..
12/08ABCELLERA BIOLOGICS : Swings to Q2 Loss; Revenue Rises
12/08ABCELLERA BIOLOGICS : Earnings Flash (ABCL) ABCELLERA BIOLOGICS Reports Q2 Revenue $28M
12/08ABCELLERA BIOLOGICS : Reports Q2 2021 Business Results
12/08Abcellera Biologics Inc. Announces Consolidated Earnings Results for the Second Quarter..
12/08EARNINGS REACTION HISTORY : AbCellera Biologics Inc, 50.0% Follow-Through Indicator, 10.8%..
04/08ABCELLERA BIOLOGICS : EQRx to Collaborate in Identifying, Manufacturing Therapeutic Antibo..
04/08EQRX : and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovativ..
04/08EQRx and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovati..
03/08ABCELLERA BIOLOGICS : Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeu..
03/08Tachyon Therapeutics, Inc. and AbCellera Collaborate to Develop Novel Antibody Therape..
22/07ABCELLERA BIOLOGICS : to Report Second Quarter 2021 Financial Results on August 12, 2021
13/07ABCELLERA BIOLOGICS : Appoints Neil Berkley as Chief Business Officer (Form 8-K)
13/07ABCELLERA BIOLOGICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
13/07ABCELLERA BIOLOGICS : Appoints Neil Berkley as Chief Business Officer
13/07ARES Security Corporation Appoints Neil Berkley as Chief Business Officer
22/06ABCELLERA BIOLOGICS : to Construct Vancouver Manufacturing Facility to Support Future Pand..
22/06ABCELLERA BIOLOGICS : Continues Expansion and Strengthens Future Pandemic Preparedness wit..
22/06AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-O..
21/06ABCELLERA BIOLOGICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
21/06ABCELLERA BIOLOGICS INC.(NASDAQGS : ABCL) added to S&P Global BMI Index
18/06PETER THIEL : Thiel-backed psychedelics startup Atai valued at $3.19 billion in Nasdaq deb..
10/06ABCELLERA BIOLOGICS : Reports Institutional Investors Purchased 11.9 Million Shares From S..
10/06ABCELLERA BIOLOGICS : Announces Secondary Private Sale of 11.9 Million Common Shares
09/06Certain Common Shares of AbCellera Biologics Inc. are subject to a Lock-Up Agreement En..
09/06Certain Options of AbCellera Biologics Inc. are subject to a Lock-Up Agreement Ending o..
17/05ABCELLERA BIOLOGICS : Results of Operations and Financial Condition, Regulation FD Disclos..
14/05ABCELLERA BIOLOGICS : Management's Discussion and Analysis of Financial Condition and Resu..
14/05SECTOR UPDATE : Health Care Stocks Rise Friday But Trail Most Other Sectors
14/05SECTOR UPDATE : Health Care Stocks Rising in Friday Afternoon Trade
13/05ABCELLERA BIOLOGICS : Swings to Q1 Profit, Revenue Surges
13/05ABCELLERA BIOLOGICS INC. : Results of Operations and Financial Condition, Regulation FD Di..
13/05ABCELLERA BIOLOGICS : Earnings Flash (ABCL) ABCELLERA BIOLOGICS Reports Q1 Revenue $203M, ..
13/05Abcellera Biologics Inc. Announces Consolidated Earnings Results for the First Quarter ..
13/05ABCELLERA BIOLOGICS : CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results
11/05ABCELLERA BIOLOGICS : to Present Virtually at Berenberg Conference on May 18, 2021
06/05ABCELLERA BIOLOGICS : Angios Collaborate Over Therapeutics to Combat Blindness Caused by D..
06/05ABCELLERA BIOLOGICS : Partners with Angios to Develop Therapeutics to Combat Blindness Cau..
06/05AbCellera Partners with Angios GmbH to Develop Therapeutics to Combat Blindness Caused ..
04/05ABCELLERA BIOLOGICS : New AbCellera-Discovered Antibody that Neutralizes Viral Variants of..
29/04AbCellera Breaks Ground on Global Headquarters in Vancouver
21/04ABCELLERA : to Report First Quarter 2021 Financial Results on May 13, 2021
1  2  3Volgende
Volgende evenement op ABCELLERA BIOLOGICS INC.
09/11/21